STOCK TITAN

Virtuix (VTIX) tests Omni One VR treadmill in physical therapy and clinical simulation collaboration

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Virtuix Holdings Inc. reported a business update, highlighting delivery of its Omni One omni-directional treadmill system to Florida Gulf Coast University for evaluation in physical therapy, rehabilitation, fall prevention, and clinical simulation settings. Faculty and students will assess how the system’s 360-degree locomotion and safety harness support gait, balance, and postural control assessments.

The collaboration showcases a potential expansion into healthcare while Virtuix continues to pursue consumer and defense markets. The press release notes the global physical therapy market is valued at about $26 billion in 2025 and projected to reach roughly $50 billion by 2034, framing a large addressable opportunity for technology-enabled rehabilitation and simulation solutions.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Global physical therapy market 2025 $26 billion Estimated global physical therapy market value in 2025
Projected physical therapy market 2034 $50 billion Projected global physical therapy market by 2034
omni-directional treadmill technical
"an Omni One omni-directional treadmill system to Florida Gulf Coast University"
An omni-directional treadmill is a motorized platform that lets a person walk or run in any direction while staying in one place, often used with virtual reality to simulate free movement. Investors care because it transforms user experience into a tangible product opportunity—think of it as a compact moving floor for VR—affecting potential market size, manufacturing costs, intellectual property, partnerships, and revenue streams tied to gaming, training, and simulation markets.
clinical simulation medical
"for use in physical therapy, occupational therapy, neurological rehabilitation, fall prevention, and clinical simulation applications"
Clinical simulation is the use of realistic models, virtual patients, or computer programs to recreate medical procedures, treatments or patient responses without involving real people. Like a flight simulator for pilots, it lets researchers and caregivers test safety, train staff and explore how a therapy might work before—or alongside—real trials. For investors, strong simulation programs can lower development risk, reduce costs and speed up time to market by identifying problems earlier.
simulation-based education medical
"Omni One may also support simulation-based education by enabling learners to navigate realistic virtual environments"
XR technical
"expanding access to the world’s largest XR user base"
XR stands for extended‑release, a drug formulation designed to release its active ingredient slowly over an extended period instead of all at once. Think of it like a slow‑release fertilizer for the body: it can reduce how often patients need a dose and smooth side effects. For investors, XR versions can change sales patterns, patient adherence, regulatory review, and competitive positioning, so they can materially affect a product’s market value and revenue outlook.
forward-looking statements regulatory
"This press release contains forward-looking statements"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
false 0001606242 0001606242 2026-04-14 2026-04-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): April 14, 2026

 

VIRTUIX HOLDINGS INC.

(Exact name of registrant as specified in its charter)

 

Delaware   001-43067   46-4371395
(State or other jurisdiction of
incorporation or organization)
  (Commission File Number)   (I.R.S. Employer
Identification No.)

 

11500 Metric Blvd, Suite 430
Austin, TX
  78758
(Address of principal executive offices)   (Zip Code)

 

(512) 947-9029

Registrant’s telephone number, including area code:

 

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Class   Trading Symbol   Name of Exchange On Which Registered
Common Stock   VTIX   Nasdaq Global Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

Item 8.01. Other Events.

 

On April 14, 2026, Virtuix Holdings Inc. (the “Company”) issued a press release (the “Press Release”) announcing an update on the Company’s business developments. A copy of the Press Release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

99.1   Press Release dated April 14, 2026.
104   Cover Page Interactive File (the cover page XBRL tags are embedded in the Inline XBRL document)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: April 14, 2026

 

  VIRTUIX HOLDINGS INC.
     
  By:  /s/ Jan Goetgeluk
    Jan Goetgeluk
    Chief Executive Officer
    (Principal Executive Officer)

 

2

Exhibit 99.1

 

 

Virtuix Delivers Omni One to Florida Gulf Coast University for Use in Physical Therapy and Clinical Simulation

  

 

University to Evaluate Omni One Across Rehabilitation and Simulation Settings

 

Collaboration Highlights Potential Expansion into Healthcare While Virtuix Continues Advancing Consumer and Defense Initiatives

 

AUSTIN, TEXAS April 14, 2026 – Virtuix Inc. (NASDAQ: VTIX), a leading developer of full-body virtual reality systems, today announced the delivery of an Omni One omni-directional treadmill system to Florida Gulf Coast University (“FGCU”), where faculty and students in the Marieb College of Health & Human Services will evaluate the system for use in physical therapy, occupational therapy, neurological rehabilitation, fall prevention, and clinical simulation applications.

 

“The Virtuix system presents strong potential as both a medical device and a clinical simulation platform. Its immersive 360-degree locomotion technology allows for objective assessment of gait, balance, stride mechanics, postural control, and reaction time. This makes it highly applicable across physical therapy and rehabilitation. The integrated safety harness creates a secure environment for progressive therapeutic interventions while minimizing fall risk,” said Dr. Joseph P. Buhain, Director of Interprofessional Simulation and Emerging Technology, Marieb College of Health & Human Services at Florida Gulf Coast University.

 

In addition to potential rehabilitation applications, Omni One may also support simulation-based education by enabling learners to navigate realistic virtual environments, including hospital units, home settings, community spaces, and disaster scenarios. Virtuix believes these capabilities can enhance situational awareness through interactive, movement-based experiences that train executive function and memory.

 

“We are excited to work with FGCU and evaluate the use of Omni One for medical applications,” said Jan Goetgeluk, CEO of Virtuix. “This collaboration potentially opens another large market for Virtuix in addition to our consumer and defense businesses. More importantly, we believe our Omni technology has the power to help patients worldwide by making physical therapy and rehabilitation exercises more engaging and effective.”

 

 

 

Physical therapy and rehabilitation represent a large and rapidly growing market opportunity. The global physical therapy market is valued at approximately $26 billion in 2025 and is projected to nearly double to approximately $50 billion by 2034, driven by an aging population, the rising prevalence of chronic and musculoskeletal conditions, and growing interest in technology-enabled care. Virtuix believes its immersive, full-body movement platform is well positioned to address this growing demand through differentiated rehabilitation and simulation use cases.

 

Virtuix remains focused on two core markets alongside this emerging medical application opportunity: consumer and defense. On the consumer side, the Company recently joined Meta’s “Made for Meta” program, which is expected to make Omni One compatible with Meta Quest headsets and content, expanding access to the world’s largest XR user base. In the defense segment, Virtuix recently announced an Omni One delivery to the U.S. Marine Corps and a development agreement with the U.S. Navy, building on prior defense traction that includes sales to the U.S. Army at West Point, the U.S. Air Force Academy, and Yokota Air Base.

 

About Virtuix

 

Virtuix Inc. (NASDAQ: VTIX) is a leading manufacturer of full-body virtual reality systems for consumer, enterprise, and defense markets. The company’s premier portfolio of “Omni” omni-directional treadmills enables players to walk and run in 360 degrees inside video games and other virtual reality applications. With a commitment to innovation, Virtuix continues to push the boundaries of XR and AI, delivering immersive experiences to users worldwide. For more information, visit virtuix.com.

 

Forward-Looking Statements

 

This press release contains forward-looking statements. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. When the Company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions that do not relate solely to historical matters, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company’s expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the uncertainties related to market conditions and the completion of the initial public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the registration statement filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company’s filings with the SEC, which are available for review at www.sec.gov. The Company undertakes no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof.

 

Visit Us on Social Media:

 

LinkedIn
Instagram
Facebook
YouTube
TikTok
X

 

Company Contact

 

Lauren Premo
Virtuix Inc.
press@virtuix.com

 

Investor Relations Contact

 

Chris Tyson
MZ Group
Direct: 949-491-8235
VTIX@mzgroup.us

 

FAQ

What business update did Virtuix Holdings (VTIX) provide in its latest 8-K?

Virtuix Holdings reported delivering an Omni One virtual reality treadmill system to Florida Gulf Coast University. The university will evaluate it for physical therapy, rehabilitation, fall prevention, and clinical simulation uses, highlighting a potential move into healthcare alongside Virtuix’s existing consumer and defense markets.

How is Virtuix (VTIX) exploring healthcare applications for its Omni One system?

Virtuix is collaborating with Florida Gulf Coast University’s Marieb College to test Omni One in physical therapy, occupational therapy, neurological rehabilitation, and fall prevention. The system’s 360-degree locomotion and safety harness aim to support objective assessment of gait, balance, and postural control in a secure therapeutic environment.

What market opportunity does Virtuix (VTIX) cite for physical therapy and rehabilitation?

Virtuix notes the global physical therapy market is about $26 billion in 2025 and projected to approach $50 billion by 2034. The company believes its immersive, full-body movement platform can address demand for technology-enabled rehabilitation and simulation within this growing healthcare segment.

Does Virtuix (VTIX) plan to maintain focus on consumer and defense markets?

Yes. Virtuix states it remains focused on consumer and defense markets while exploring medical applications. The company recently joined Meta’s “Made for Meta” program for Omni One compatibility and announced deliveries and agreements with U.S. defense organizations, including the Marine Corps and Navy, building on prior military deployments.

What is the role of Florida Gulf Coast University in Virtuix’s Omni One initiative?

Florida Gulf Coast University’s Marieb College faculty and students will evaluate Omni One in rehabilitation and clinical simulation environments. They will explore uses in physical and occupational therapy, neurological rehabilitation, fall prevention, and simulation-based education across hospital units, home settings, community spaces, and disaster scenarios.

How does Virtuix (VTIX) describe the potential benefits of Omni One in education and simulation?

Virtuix indicates Omni One may support simulation-based education by letting learners move through realistic virtual environments. The company believes these experiences can enhance situational awareness and help train executive function and memory through interactive, movement-based scenarios reflective of real-world healthcare and community settings.

Filing Exhibits & Attachments

4 documents